Morning Market Losers

Threshold Pharmaceuticals THLD fell 28.10% to $6.27 at 9:55 am. Threshold Pharmaceuticals announced data from Phase 2b clinical trial of TH-302 in combination with Gemcitabine. Targacept TRGT shares dipped 11.34% to $4.30. Targacept reported top-line results from a Phase 2 trial of TC-5619 in adults with inattentive-predominant attention deficit/hyperactivity disorder. Tandy Brands Accessories TBAC shares lost 10.74% to $1.33. Tandy Brands Accessories' trailing-twelve-month ROE is -12.63%. MGC Diagnostics MGCD dropped 10.51% to $5.28. MGC Diagnostics' trailing-twelve-month operating margin is -1.93%.